4//SEC Filing
Seelenberger Alexander A. 4
Accession 0000950170-24-066215
CIK 0001796129other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 9:12 PM ET
Size
5.7 KB
Accession
0000950170-24-066215
Insider Transaction Report
Form 4
Seelenberger Alexander A.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-05-23+31,250→ 125,000 totalExercise: $7.38Exp: 2034-03-06→ Common Stock (31,250 underlying)
Footnotes (2)
- [F1]The option grant was approved on March 7, 2024, subject to stockholder approval of an amendment to the Vincerx Pharma, Inc. 2020 Stock Incentive Plan. The stockholders approved the amendment on May 23, 2024.
- [F2]One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.
Documents
Issuer
Vincerx Pharma, Inc.
CIK 0001796129
Entity typeother
Related Parties
1- filerCIK 0001832562
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 9:12 PM ET
- Size
- 5.7 KB